文献速递生殖医学

制瘤素M:一种促进人类卵巢排卵过程的新型白细胞来源因子

Oncostatin-M: a novel leukocyte-derived factor facilitating the ovulatory process in the human ovary.
PubMed 文献 · Hum Reprod · 2025-01-01

该研究分析了自然周期女性优势卵泡(n=19)和IVF患者卵泡抽吸液(n=12),发现白细胞来源的制瘤素M(OSM)在hCG后表达增加,可激活人排卵前颗粒细胞的STAT3、ERK1/2、AKT和p38MAPK通路,并调节类固醇生成、前列腺素合成和组织重塑。

要点

  • OSM在卵泡白细胞中特异性表达,其受体主要在颗粒细胞表达,hCG后两者表达均增加(P<0.05)。
  • 重组人OSM激活hGLCs中STAT3、ERK1/2、AKT和p38MAPK通路。
  • rhOSM增加孕酮和PGE2分泌(P<0.05),降低雌二醇生成(P<0.05)。

核心结论

  • 白细胞来源的OSM是调节人类排卵事件的关键细胞因子,为卵泡内免疫内分泌交互提供了新见解。

研究设计与样本

  • 研究分析自然周期女性优势卵泡(n=19)和IVF患者卵泡抽吸液(n=12),并用hCG和/或重组人OSM处理原代人颗粒/黄体细胞(hGLCs)评估功能效应。

主要发现

  • 单细胞RNA测序生物信息学分析显示OSM仅表达于白细胞,其受体主要表达于颗粒细胞。
  • 免疫组化和qPCR分析显示排卵hCG给药后白细胞中OSM表达和颗粒细胞中受体表达分别增加(P<0.05)。
  • 蛋白质印迹显示rhOSM处理激活hGLCs中STAT3、ERK1/2、AKT和p38MAPK通路。
  • RNA测序及后续qPCR显示rhOSM诱导类固醇生成、前列腺素合成/转运、炎症和组织重塑相关基因的显著转录变化(FDR<0.05)。
  • 功能上,rhOSM增加孕酮和PGE2分泌(P<0.05),同时降低雌二醇生成(P<0.05)。

局限性

  • 本研究使用体外hGLC培养,可能无法完全重现体内排卵动态。
  • 研究结果仅来自人类样本,需在其他哺乳动物物种中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Does leukocyte-derived Oncostatin-M (OSM) regulate the ovulatory process in human dominant follicles? SUMMARY ANSWER: Leukocyte-derived OSM activates key signaling pathways in human preovulatory granulosa cells and modulates steroidogenesis, prostaglandin synthesis, and tissue remodeling in human ovulatory follicles. WHAT IS KNOWN ALREADY: Leukocytes are essential regulators of ovulation. Our recent single-cell RNA sequencing (scRNA-seq) has identified diverse leukocyte subpopulations in follicular aspirates obtained from IVF patients and revealed the expression of OSM in leukocytes and its receptors (OSMR, LIFR, IL6ST) in follicular cells. However, the function of leukocyte-derived OSM in human ovulatory follicle remains unclear. STUDY DESIGN, SIZE, DURATION: This study analyzed dominant follicles from naturally cycling women (n = 19) across the periovulatory period and follicular aspirates from IVF patients (n = 12). Primary human granulosa/lutein cells (hGLCs) treated with hCG and/or recombinant human OSM (rhOSM) were used to assess its functional effects. PARTICIPANTS/MATERIALS, SETTING, METHODS: Our recent scRNA-seq dataset was used to identify cell types expressing OSM and its receptors in human follicular aspirates. The expression of OSM and its receptors was assessed in dominant follicles by quantitative PCR (qPCR) and immunohistochemistry. hGLCs were treated with hCG and/or rhOSM, and functional analyses included qPCR, western blotting, RNA sequencing, and hormone assays for progesterone (P4), estradiol (E2), and prostaglandin E2 (PGE2) production. MAIN RESULTS AND THE ROLE OF CHANCE: Bioinformatics analysis of scRNA-seq revealed that OSM is exclusively expressed in leukocytes, whereas its receptors are predominantly expressed in granulosa cells. Immunohistochemistry and qPCR analyses exhibited increased OSM expression in leukocytes and receptor expression in granulosa cells, respectively, after ovulatory hCG administration (P < 0.05). Western blotting demonstrated that rhOSM treatment activated STAT3, ERK1/2, AKT, and p38MAPK pathways in hGLCs. RNA sequencing and following qPCR revealed rhOSM-induced significant transcriptional changes in genes involved in steroidogenesis, prostaglandin synthesis/transport, inflammation, and tissue remodeling (FDR < 0.05). Functionally, rhOSM increased P4 and PGE2 secretion (P < 0.05) while decreasing E2 production (P < 0.05), suggesting a role in ovulation and luteinization. LARGE SCALE DATA: RNA sequencing datasets are available in the Gene Expression Omnibus under accession number GSE277343. LIMITATIONS, REASONS FOR CAUTION: This study was conducted using in vitro hGLC cultures, which may not fully recapitulate in vivo ovulatory dynamics. Additionally, the findings are specific to human samples and require validation in other mammalian species. WIDER IMPLICATIONS OF THE FINDINGS: These results suggest that leukocyte-derived OSM is a key cytokine regulating ovulatory events, providing novel insights into the immunoendocrine crosstalk within the human follicle. This study enhances our understanding of cytokine-mediated follicular maturation and may have implications for improving ovulation-related fertility treatments. STUDY FUNDING/COMPETING INTERESTS: This study was supported by grants P01HD71875 (to M.J. and T.E.C.), R01HD096077 (to M.J.), R03HD095098 (to Y.C.), and R01HD115554 (to Y.C.). The authors declare no competing interests.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Choi Y, Brännström M, Akin JW, et al. Oncostatin-M: a novel leukocyte-derived factor facilitating the ovulatory process in the human ovary. Hum Reprod. 2025. PMID: 40327872. doi:10.1093/humrep/deaf076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。